Chair (National Director), Department of Radiation Oncology, Cancer Treatment Centers of America
Radiation Oncology
Dr. Richard B. Wilder, MD
|
|
Give Review
Richard Wilder practices Radiation Oncology. He studied medicine at University of Maryland School of Medicine. University of Maryland School of Medicine is ranked 37 in research and 52 in primary care medicine Doctor Richard B. Wilder, MD is a published physician. He published 76 publications, including: 'A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapy.' Doctor Richard B. Wilder, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Kidney cancer, version 3.2015.
- A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer.
- Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancer.
- Outcomes and treatment patterns as a function of time in stage IS testicular seminoma: A population-based analysis.
- ACR appropriateness criteria® pediatric hodgkin lymphoma.
- Primary bladder preservation treatment for urothelial bladder cancer.
- Kidney cancer.
- ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II.
- Cross-linked hyaluronan gel improves the quality of life of prostate cancer patients undergoing radiotherapy.
- Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status.
- Preliminary Results in 173 Breast Cancer Patients Treated with Post-Lumpectomy MammoSite Single-Lumen Brachytherapy or Multi-Catheter Brachytherapy.
- Preliminary results in prostate cancer patients treated with high-dose-rate brachytherapy and intensity modulated radiation therapy (IMRT) vs. IMRT alone.
- Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer.
- A prospective study of intrafraction prostate motion in the prone vs. supine position.
- ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.
- Preliminary results with accelerated partial breast irradiation in high-risk breast cancer patients.
- A Contura catheter offers dosimetric advantages over a MammoSite catheter that increase the applicability of accelerated partial breast irradiation.
- Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors.
- Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.
- Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reactio...
- Stage III follicular lymphoma: long-term follow-up and patterns of failure.
- Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.
- Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemothe...
- Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma.
- Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.
- Clinical implications of incorporating heterogeneity corrections in mantle field irradiation.
- Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
- An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
- Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.
- International prognostic index-based outcomes for diffuse large B-cell lymphomas.
- The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma.
- European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin di...
- Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
- Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical deb...
- External beam radiation therapy and a low-dose-rate brachytherapy boost without or with androgen deprivation therapy for prostate cancer.
- Lipiodol as a fiducial marker for image-guided radiation therapy for bladder cancer.
- Pharmacodynamic effects of ketoprofen on crevicular fluid prostanoids in adult periodontitis.
- Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer.
- A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapy.
- Treatment of cancer with intratumoral infusion of radioisotopes.
- Radioimmunotherapy: recent results and future directions.
- Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung ca...
- Effects of stem cell factor on the growth and radiation survival of tumor cells.
- Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy.
- A comparison of arc-based and static mini-multileaf collimator-based radiosurgery treatment plans.
- Recent advances in radiotherapy for head and neck cancers.
- Recurrent basal cell carcinoma treated with radiation therapy.
- Concurrent twice-weekly paclitaxel and thoracic irradiation for stage III non-small cell lung cancer.
- Pterygium treated with excision and postoperative beta irradiation.
- Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or wit...
- Merkel cell carcinoma. Improved locoregional control with postoperative radiation therapy.
- The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts.
- Radiation therapy for squamous cell carcinoma of the skin.
- Long-term results with radiotherapy for Stage I-II follicular lymphomas.
- Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
- Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
- The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin''s disease.
- Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406.
- Radiation therapy for malignant lymphoma: enduring importance in the era of systemic therapy.
- Impact of collimator leaf width on stereotactic radiosurgery and 3D conformal radiotherapy treatment plans.
- Basal cell carcinoma treated with radiation therapy.
- Candidates for prostate radioactive seed implantation treated by external beam radiotherapy.
- Preliminary results of three-dimensional conformal radiotherapy as salvage treatment for a rising prostate-specific antigen level postprostatectomy.
- Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
- Localized non-Hodgkin lymphoma involving the thyroid gland.
- Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma.
- Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.
- Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-bas...
- Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
- Localization of the prostatic apex for radiotherapy treatment planning using urethroscopy.
- Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy.
- Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results.
- Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin''s disease treated with radiotherapy.
- Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas.
- Uncertainties in contemporary treatment of aggressive lymphomas.
Schools
University Of Maryland School Of Medicine
Greater Baltimore Med Center
University Ariz
Stanford University
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
University of Arizona -
University of Maryland School of Medicine
Drug Facts
| NPI NUMBER | 1801948112 | |
| NPPES Provider LastName | WILDER | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 336129416 | |
| NPPES Provider State | FL | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 39.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801948112 |
| Last Name Of The Provider | WILDER |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
Dr. Arash O. Naghavi, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Sarah E. Hoffe, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William A. Assad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cornelius I. Turalba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Koval, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas J. Dilling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jimmy J. Caudell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roberto Diaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sophia M. Edwards-Bennett, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ravi Shridhar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine K. Park Leonard, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael Tomblyn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Niroo B. Talwar, MD
This Doctor is OpenDoctor Recommended.
|